[vc_row][vc_column width=”3/4″][vc_message]The Asia-Pacific joint pain injections market is forecasted to grow with a CAGR of 8.84% during the projected years of 2022 to 2030. The market growth is fueled by the rising focus of market players in the region, the augmenting incidence of orthopedic diseases, increased healthcare expenditure, the surging population, and the availability of…
The Europe joint pain injections market is expected to progress with a CAGR of 8.30%, during the forecasted period of 2022-2030. Request a Free Sample Report.
[vc_row][vc_column width=”3/4″][vc_message]The North America joint pain injections market is evaluated to develop with a CAGR of 8.69% over the forecast period of 2022 to 2030. Factors such as the rising demand for advanced therapeutic platforms for joint pain to enhance treatment outcomes, in addition to the increasing number of new product approvals as well as…
The Japan joint pain injections market is expected to progress with a CAGR of 8.57%, during the forecasting period of 2022-2028. Request a free sample report.
[vc_row][vc_column][vc_column_text] [/vc_column_text][/vc_column][/vc_row][vc_row][vc_column width=”3/4″][vc_message]In terms of revenue, the global biomaterials market was valued at $115.02 billion in 2021, and is expected to reach $269.55 billion by 2030, growing at a CAGR of 12.78% during the forecast period. [/vc_message][vc_row_inner el_class=”an-report-custom-heading” css=”.vc_custom_1505382055404{margin-bottom: 32px !important;}”][vc_column_inner width=”1/6″][vc_single_image image=”7478″][/vc_column_inner][vc_column_inner width=”5/6″][vc_column_text] GLOBAL BIOMATERIALS MARKET FORECAST 2022-2030 Global Biomaterials Market by Product (Metal-based…